Announcements Trials

Browse Landscape

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Adrenal Gland Neoplasms 2 Urinary Bladder Neoplasms 1 Pheochromocytoma 1 Carcinoma, Renal Cell 1

Interventions

3-Iodobenzylguanidine 5 Doxorubicin 3 cabozantinib 2 Temozolomide 2 Radiotherapy 2 Phenoxybenzamine 2 Ifosfamide 2 Filgrastim 2 Everolimus 2 Doxazosin 2 Dexmedetomidine 2 vatalanib 1 temsirolimus 1 pegfilgrastim 1 lenvatinib 1 fostamatinib 1 atezolizumab 1 anlotinib 1 Vinorelbine 1 Tamoxifen 1 Sunitinib 1 Stem Cell Transplantation 1 Sirolimus 1 Saline Solution 1 Quality of Life 1 Patient Reported Outcome Measures 1 Oxaliplatin 1 Observation 1 Molecular Diagnostic Techniques 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pheochromocytoma × Adrenalectomy × Clear all

NCT06062082 2025-02-13

HEMODADRE

Central Hospital, Nancy, France

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡